Multiplikator Forward P/S: Asensus Surgical Inc (ASXC)
Asensus Surgical, Inc. (ASXC) generates revenue through the sale of disposable instruments and AI licenses for its robots. This forward P/S chart visualizes these expectations, where the value 9.70 determines the parameter status. The business faces challenges competing against an industry monopolist without unique advantages; however, a stable workforce of loyal engineers and software developers ensures reliable technological support for the company.
Ringkesan rincian data analitis asensus.com (ASXC)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Asensus Surgical, Inc.|ASXC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Asensus Surgical|ASXC - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku ASXC|ASXC - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Asensus Surgical|Rasio cepet asensus.com
- rincian asil keuangan lan kelipatan valuasi:
ASXC - Penghasilan resik perusahaan|Bathi sing dikarepake Asensus Surgical, Inc.|ASXC - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Asensus Surgical|ASXC - Pangali PEG|Pangali EV/EBITDA ASXC|ASXC - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Asensus Surgical|ASXC - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan asensus.com|ASXC - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Asensus Surgical, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:ASXC (TransEnterix)
The forward P/S is calculated as the ratio of current market capitalization to projected revenue, measuring market expectations regarding business growth rates. The stability of this ratio determines the maturity of the model, where the efficiency of surgical robot logistics and consumables supply directly impacts revenue, which this forward price-to-sales chart clearly reflects when analyzing the investment attractiveness of Asensus Surgical, Inc. (ASXC).
Karo sapa Asensus Surgical, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|Beyond Air (XAIR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Profusa|STRATA Skin (SSKN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S GCTK|NAOV - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Venus Concept Inc. VERO|NUWE: Kapitalisasi marang prakiraan pendapatan|AEMD - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Avinger Inc. AVGR|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|Cutera Inc (CUTR) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|inarimedical.com (NARI) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
